NexGel, Inc. NXGL 深 沪
已收盘 08-01 16:00:00 美东时间
2.57
+0.320
+14.23%
华盛通- 最 高2.6818
- 今 开2.20
- 成交量 11.32万股
- 最 低 2.20
- 昨 收 2.2498
- 总市值 1967.21万
- 52周最高 5.10
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.10
- 委 比 20.00%
- 总股本 765.45万
- 历史最高 5.10
- 量 比 1.40
- 振 幅 21.42%
- 历史最低 1.09
- 每 手 1
- 风险率 0.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NEXGEL shares are trading higher after the company announced a $950K registered direct offering.
NEXGEL shares are trading higher after the company announced a $950K registered...
08-02 01:57
NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement
NEXGEL, Inc. (NASDAQ: NXGL) announced the issuance and sale of 413,044 shares of common stock at $2.30 per share, along with warrants to purchase up to 206,522 shares with an exercise price of $4.25 per share and a 5-year term. The financing, combined with existing cash and a $1 million non-dilutive advance, strengthens the company's balance sheet and supports anticipated growth. Alere Financial Partners acted as the placement agent. The shares a...
08-01 12:00
NEXGEL Expands Partnership With STADA To Launch New Digestive And Skin Care Products, Receives $1M Non-Dilutive Funding
NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced expanding its partnership with
07-14 21:04
NEXGEL and STADA AG Announce Expansion of Partnership for North America
NEXGEL, Inc. expands partnership with STADA Arzneimittel AG to launch digestive enzyme formulas and scar/stretch mark solutions in North America. STADA provides $1 million in non-dilutive capital for product launches and marketing. NEXGEL CEO Adam Levy expressed gratitude for STADA’s support and its acceleration of their joint go-to-market strategy.
07-14 13:00
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Vaxart (NASDAQ:VXRT) stock rose 35.9% to $0.73 during Friday's regular...
06-14 01:06
Nexgel, Inc. Reports Strong Growth in Earnings Call
Nexgel, Inc. (($NXGL)) has held its Q1 earnings call. Read on for the main high...
05-16 09:56
NexGel Q1 EPS $(0.09) Beats $(0.10) Estimate, Sales $2.81M Beat $2.73M Estimate
NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. This is a 35.71 percent increase over losses of $(0.14) per share from the same
05-14 04:08
Earnings Scheduled For May 13, 2025
Companies Reporting Before The Bell • Endeavour Silver (NYSE:EXK) is estimated ...
05-13 16:32
A Peek at NexGel's Future Earnings
NexGel (NASDAQ:NXGL) will release its quarterly earnings report on Tuesday, 202...
05-13 02:12
NEXGEL reports Q4 results
NEXGEL press release (NASDAQ:NXGL): Q4 Revenue of $3.04M beats by $0.05M. Net loss for Q4 2024was $0.85 million, compared to $1.10 million in Q4 2023 and $0.69 million in Q3 2024. Q4 2024 includes a n...
03-25 04:17
